AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Report for October

AB Corporate Bond ETF (NASDAQ:EYEG) was the recipient of a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 950 shares, an increase of 104.3% from the September 30th total of 465 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 463 shares, the short-interest ratio is presently 2.1 days.

AB Corporate Bond ETF Price Performance

Shares of EYEG stock traded up $0.01 during trading hours on Friday, hitting $33.88. The company had a trading volume of 904 shares, compared to its average volume of 556. AB Corporate Bond ETF has a 12 month low of $33.24 and a 12 month high of $36.46. The firm has a market capitalization of $27.10 million, a price-to-earnings ratio of -20.16 and a beta of 0.20. The firm’s fifty day moving average is $33.90 and its 200 day moving average is $34.94. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.07 and a current ratio of 3.07.

AB Corporate Bond ETF Increases Dividend

The business also recently declared a monthly dividend, which was paid on Tuesday, October 6th. Investors of record on Thursday, October 1st were paid a $0.1367 dividend. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $1.64 annualized dividend and a yield of 4.8%. This is a positive change from AB Corporate Bond ETF’s previous monthly dividend of $0.1284. AB Corporate Bond ETF’s payout ratio is presently -101.79%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.